{"title":"[Testing of antibodies against serogroup C Neisseria meningitidis by serum bactericidal assay in healthy population, Liaoning province].","authors":"Shu-Yi An, Li Xu, Yi-Xing Li","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To test the serum antibodies from healthy population by Serum Bactericidal Assay (SBA), in order to evaluate the level of protective antibodies against serogroup C Neisseria meningitidis in Liaoning province.</p><p><strong>Methods: </strong>240 serum samples were selected from eight age-group randomly. Serogroup C vaccine candidate strain (C11) and the prevail serogroup C strain (053442) were used for SBA.</p><p><strong>Results: </strong>48.33% of 240 serum samples were positive (titer > or = 1:2) to C11 vaccine strain. Protective rate of SBA was 35.83% (titer > or = 1:8), in which, > or = 6 years old were 13.33%, 7-19 years old was 61.67%, 20-39 years old were 46.67% and > or = 40 years old were 63.33%. Rate of SBA to 053442 was lower than that to C11 in the group over 15 years old by statistic analysis.</p><p><strong>Conclusion: </strong>Population under 6 years old showed lower SBA capacities. With the implemention of Expanded Program on Immunization, children under 3 years old should be considered how to give them meningococcal vaccine in order to improve the titer of antibodies against Neisseria meningitidis serogroup C.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疫苗和免疫","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To test the serum antibodies from healthy population by Serum Bactericidal Assay (SBA), in order to evaluate the level of protective antibodies against serogroup C Neisseria meningitidis in Liaoning province.
Methods: 240 serum samples were selected from eight age-group randomly. Serogroup C vaccine candidate strain (C11) and the prevail serogroup C strain (053442) were used for SBA.
Results: 48.33% of 240 serum samples were positive (titer > or = 1:2) to C11 vaccine strain. Protective rate of SBA was 35.83% (titer > or = 1:8), in which, > or = 6 years old were 13.33%, 7-19 years old was 61.67%, 20-39 years old were 46.67% and > or = 40 years old were 63.33%. Rate of SBA to 053442 was lower than that to C11 in the group over 15 years old by statistic analysis.
Conclusion: Population under 6 years old showed lower SBA capacities. With the implemention of Expanded Program on Immunization, children under 3 years old should be considered how to give them meningococcal vaccine in order to improve the titer of antibodies against Neisseria meningitidis serogroup C.
目的:采用血清杀菌试验(SBA)检测健康人群血清抗体,评价辽宁省人群血清C群脑膜炎奈瑟菌保护性抗体水平。方法:从8个年龄组随机抽取240份血清样本。SBA采用血清C组疫苗候选株(C11)和流行的血清C组株(053442)。结果:240份血清标本C11疫苗株阳性(滴度>或= 1:2)为48.33%。SBA的保护率为35.83%(滴度> or = 1:8),其中> or = 6岁为13.33%,7-19岁为61.67%,20-39岁为46.67%,> or = 40岁为63.33%。统计分析表明,15岁以上年龄组中,对053442的SBA率低于C11。结论:6岁以下儿童的SBA能力较低。随着扩大免疫规划的实施,应考虑如何给3岁以下儿童接种脑膜炎球菌疫苗,以提高抗脑膜炎奈瑟菌C血清组抗体的滴度。